Spectranetics Unfazed By Study On Laser Use For In-Stent Restenosis
This article was originally published in The Gray Sheet
Executive Summary
Spectranetics is confident that clinical trials for the firm's CVX-300 excimer laser will demonstrate the device to be effective in treating in-stent restenosis despite unfavorable results reported in a recently completed independent study.